Skip to main content

Table 1 Characteristics of studies included for meta-analysis

From: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

First author Year Duration (months) Histology Stage Patient number Quality score Detection Platform
Yuan A [40] 2000 28 NSCLC I–III 58 8 Microarray Perkin-Elmer Applied Biosystems
Tang H [41] 2013 120 NSCLC I–III 176 9 Microarray IlluminaHumanWG-6v3.0
Raponi M [42] 2006 144 SQC I–III 129 8 Microarray AffymetrixHgu133plus2.0
Tomida S [43] 2009 109.8 ADC I–III 117 9 Microarray AgilentWholeHumanGenomeMicroarray 4x44K G4112F
Botling J [44] 2013 120 NSCLC I–IV 196 8 Microarray AffymetrixHgu133plus2.0
Beer DG [45] 2002 110.6 ADC I–III 86 8 Microarray AffymetrixHumanFullLength HuGeneFL
Landi MT [46] 2008 NR ADC I–IV 74 9 Microarray AffymetrixHgu133a
Lu T [47] 2010 NR ADC I–IV 60 8 Microarray AffymetrixHgu133plus2.0
Selamat SA [48] 2012 NR ADC I–III 58 8 Microarray IlluminaHumanWG-6v3.0 expression
Meyerson M [49] 2015 NR SQC I–IV 135 8 Microarray AffymetrixHgu133a
  1. Cutoff value: median expression
  2. NR not reporting, ADC lung adenocarcinoma, SQC lung squamous cell carcinoma